Amira Guirguis
Amira Guirguis
Swansea University Medical School
Verified email at swansea.ac.uk - Homepage
Title
Cited by
Cited by
Year
Abuse of prescription drugs in the context of novel psychoactive substances (NPS): a systematic review
F Schifano, S Chiappini, JM Corkery, A Guirguis
Brain sciences 8 (4), 73, 2018
282018
Analysis of ‘legal high’substances and common adulterants using handheld spectroscopic techniques
S Assi, A Guirguis, S Halsey, S Fergus, JL Stair
Analytical Methods 7 (2), 736-746, 2015
272015
The “endless trip” among the NPS users: psychopathology and psychopharmacology in the hallucinogen-persisting perception disorder. A systematic review
L Orsolini, GD Papanti, D De Berardis, A Guirguis, JM Corkery, F Schifano
Frontiers in psychiatry 8, 240, 2017
242017
Intended and unintended use of cathinone mixtures
A Guirguis, JM Corkery, JL Stair, SB Kirton, M Zloh, F Schifano
Human Psychopharmacology: Clinical and Experimental 32 (3), e2598, 2017
232017
Identification of new psychoactive substances (NPS) using handheld Raman Spectroscopy employing both 785 and 1064 nm laser sources
A Guirguis, S Girotto, B Berti, JL Stair
Forensic science international 273, 113-123, 2017
222017
An insight into Z-drug abuse and dependence: an examination of reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions
F Schifano, S Chiappini, JM Corkery, A Guirguis
International Journal of Neuropsychopharmacology 22 (4), 270-277, 2019
152019
Psychedelic fauna for psychonaut hunters: a mini-review
L Orsolini, M Ciccarese, D Papanti, D De Berardis, A Guirguis, JM Corkery, ...
Frontiers in Psychiatry 9, 153, 2018
132018
Assessing the 2004–2018 fentanyl misusing issues reported to an international range of adverse reporting systems
F Schifano, S Chiappini, JM Corkery, A Guirguis
Frontiers in pharmacology 10, 46, 2019
122019
New/emerging psychoactive substances and associated psychopathological consequences
F Schifano, F Napoletano, S Chiappini, A Guirguis, JM Corkery, ...
Psychological medicine, 1-13, 2019
92019
Exploration of the use of new psychoactive substances by individuals in treatment for substance misuse in the UK
R Gittins, A Guirguis, F Schifano, I Maidment
Brain sciences 8 (4), 58, 2018
92018
Drowning in diversity? A systematic way of clustering and selecting a representative set of new psychoactive substances
M Zloh, EG Samaras, J Calvo-Castro, A Guirguis, JL Stair, SB Kirton
RSC advances 7 (84), 53181-53191, 2017
92017
The clinical challenges of synthetic cathinones
F Schifano, F Napoletano, D Arillotta, C Zangani, L Gilgar, A Guirguis, ...
British Journal of Clinical Pharmacology 86 (3), 410-419, 2020
82020
Survey of knowledge of legal highs (novel psychoactive substances) amongst London pharmacists
A Guirguis, JM Corkery, JL Stair, S Kirton, M Zloh, CM Goodair, F Schifano, ...
Drugs and Alcohol Today, 2015
82015
New psychoactive substances: A public health issue
A Guirguis
International Journal of Pharmacy Practice, 2017
62017
Detection of newly emerging psychoactive substances using Raman spectroscopy and chemometrics
J Calvo-Castro, A Guirguis, EG Samaras, M Zloh, SB Kirton, JL Stair
RSC advances 8 (56), 31924-31933, 2018
42018
Focus on clozapine withdrawal-and misuse-related cases as reported to the European Medicines Agency (EMA) pharmacovigilance database
S Chiappini, F Schifano, JM Corkery, A Guirguis
Brain Sciences 10 (2), 105, 2020
22020
'New/Designer Benzodiazepines': an analysis of the literature and psychonauts' trip reports.
L Orsolini, JM Corkery, S Chiappini, A Guirguis, A Vento, D De Berardis, ...
Current neuropharmacology, 2020
22020
The use of new psychoactive substances (NPS) in young people and their role in mental health care: a systematic review
L Orsolini, S Chiappini, JM Corkery, A Guirguis, D Papanti, F Schifano
Expert review of neurotherapeutics 19 (12), 1253-1264, 2019
22019
New Psychoactive Substances (NPS), Psychedelic Experiences and Dissociation: Clinical and Clinical Pharmacological Issues
F Schifano, F Napoletano, S Chiappini, L Orsolini, A Guirguis, JM Corkery, ...
Current Addiction Reports 6 (2), 140-152, 2019
22019
Synthetic cathinones—Prevalence and motivations for use
JM Corkery, A Guirguis, DG Papanti, L Orsolini, F Schifano
Synthetic Cathinones, 153-189, 2018
22018
The system can't perform the operation now. Try again later.
Articles 1–20